S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
NYSE:DDS

Dillard's (DDS) Stock Price, News & Analysis

$408.43
+6.62 (+1.65%)
(As of 04/19/2024 ET)
Today's Range
$400.04
$411.69
50-Day Range
$395.75
$475.49
52-Week Range
$272.58
$476.48
Volume
76,915 shs
Average Volume
86,625 shs
Market Capitalization
$6.63 billion
P/E Ratio
9.12
Dividend Yield
0.24%
Price Target
$305.67

Dillard's MarketRank™ Stock Analysis

Analyst Rating
Reduce
1.50 Rating Score
Upside/​Downside
25.2% Downside
$305.67 Price Target
Short Interest
Bearish
12.90% of Float Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
-2.00
Upright™ Environmental Score
News Sentiment
0.39mentions of Dillard
Based on 5 Articles This Week
Insider Trading
Selling Shares
$205,605 Sold Last Quarter
Proj. Earnings Growth
-4.17%
From $32.59 to $31.23 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.22 out of 5 stars

Retail/Wholesale Sector

140th out of 201 stocks

Department Stores Industry

4th out of 4 stocks

DDS stock logo

About Dillard's Stock (NYSE:DDS)

Dillard's, Inc. operates retail department stores in the southeastern, southwestern, and midwestern areas of the United States. The company's stores offer merchandise, including fashion apparel for women, men, and children; and accessories, cosmetics, home furnishings, and other consumer goods. It also engages in the general contracting construction activities. Dillard's, Inc. was founded in 1938 and is based in Little Rock, Arkansas.

DDS Stock Price History

DDS Stock News Headlines

Double your money before lunch?
Unlike bacterial infections, viral infections can be difficult to treat with medicine. Usually, if you've got a virus, your doctor's best advice is to simply rest and allow your immune system to fight back. Antiviral medications prevent viruses from reproducing, but they can't actually stop the virus. However, scientists may have just found a new way to fight back.
Dillard's, Inc. (DDS)
Dillard’s Launches Caelynn Bell for Gianni Bini
Double your money before lunch?
Unlike bacterial infections, viral infections can be difficult to treat with medicine. Usually, if you've got a virus, your doctor's best advice is to simply rest and allow your immune system to fight back. Antiviral medications prevent viruses from reproducing, but they can't actually stop the virus. However, scientists may have just found a new way to fight back.
Dillard's: Post-COVID Party Is Over, Time To Sell
Dillard's Introduces Katherine Mason for Kinesis
Dillard’s Introduces Katherine Mason for Kinesis
KSS Mar 2024 33.500 call
KSS Mar 2024 25.500 put
Dillard's, Inc. Announces $0.25 Cash Dividend
Dillard's Full Year 2024 Earnings: EPS Beats Expectations
Dillard's: Fiscal Q4 Earnings Snapshot
Dillard’s Launches The Style Bungalow for Antonio Melani
Dillard's Launches The Style Bungalow for Antonio Melani
See More Headlines
Receive DDS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Dillard's and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Ex-Dividend for 2/5 Dividend
12/28/2023
Dividend Payable
2/05/2024
Last Earnings
2/26/2024
Ex-Dividend for 5/6 Dividend
3/27/2024
Today
4/21/2024
Dividend Payable
5/06/2024
Next Earnings (Estimated)
5/09/2024
Fiscal Year End
1/31/2025

Industry, Sector and Symbol

Industry
Department stores
Sub-Industry
Department Stores
CUSIP
25406710
Employees
29,600
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$305.67
High Stock Price Target
$450.00
Low Stock Price Target
$190.00
Potential Upside/Downside
-25.2%
Consensus Rating
Reduce
Rating Score (0-4)
1.50
Research Coverage
2 Analysts

Profitability

Net Income
$738.85 million
Pretax Margin
13.33%

Debt

Sales & Book Value

Annual Sales
$6.75 billion
Cash Flow
$54.46 per share
Book Value
$104.56 per share

Miscellaneous

Free Float
10,744,000
Market Cap
$6.63 billion
Optionable
Not Optionable
Beta
0.95
Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

DDS Stock Analysis - Frequently Asked Questions

Should I buy or sell Dillard's stock right now?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Dillard's in the last year. There are currently 1 sell rating and 1 hold rating for the stock. The consensus among Wall Street analysts is that investors should "reduce" DDS shares.
View DDS analyst ratings
or view top-rated stocks.

What is Dillard's' stock price target for 2024?

2 analysts have issued 1-year price targets for Dillard's' stock. Their DDS share price targets range from $190.00 to $450.00. On average, they anticipate the company's stock price to reach $305.67 in the next twelve months. This suggests that the stock has a possible downside of 25.2%.
View analysts price targets for DDS
or view top-rated stocks among Wall Street analysts.

How have DDS shares performed in 2024?

Dillard's' stock was trading at $403.65 at the beginning of the year. Since then, DDS stock has increased by 1.2% and is now trading at $408.43.
View the best growth stocks for 2024 here
.

When is Dillard's' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 9th 2024.
View our DDS earnings forecast
.

How were Dillard's' earnings last quarter?

Dillard's, Inc. (NYSE:DDS) issued its earnings results on Monday, February, 26th. The company reported $13.69 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $11.59 by $2.10. The company earned $2.12 billion during the quarter, compared to the consensus estimate of $2.08 billion. Dillard's had a trailing twelve-month return on equity of 40.90% and a net margin of 10.94%.

How often does Dillard's pay dividends? What is the dividend yield for Dillard's?

Dillard's declared a quarterly dividend on Thursday, February 29th. Investors of record on Thursday, March 28th will be given a dividend of $0.25 per share on Monday, May 6th. This represents a $1.00 annualized dividend and a dividend yield of 0.24%. The ex-dividend date of this dividend is Wednesday, March 27th.
Read our dividend analysis for DDS
.

Is Dillard's a good dividend stock?

Dillard's (NYSE:DDS) pays an annual dividend of $1.00 per share and currently has a dividend yield of 0.24%. The company does not yet have a strong track record of dividend growth. The dividend payout ratio is 2.23%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, DDS will have a dividend payout ratio of 3.20% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for DDS.

What is Bill Dillard II's approval rating as Dillard's' CEO?

2,306 employees have rated Dillard's Chief Executive Officer Bill Dillard II on Glassdoor.com. Bill Dillard II has an approval rating of 46% among the company's employees. This puts Bill Dillard II in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Dillard's own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Dillard's investors own include Intel (INTC), Walt Disney (DIS), Micron Technology (MU), Cisco Systems (CSCO), CVS Health (CVS), General Electric (GE), Abbott Laboratories (ABT), Advanced Micro Devices (AMD), Gilead Sciences (GILD) and Hawkins (HWKN).

Who are Dillard's' major shareholders?

Dillard's' stock is owned by a number of retail and institutional investors. Top institutional shareholders include Hexagon Capital Partners LLC (0.26%), Hennessy Advisors Inc. (0.08%), Park National Corp OH (0.00%), Monument Capital Management (0.00%) and CWM LLC (0.00%). Insiders that own company stock include Chris B Johnson, Dean L Worley, J C Watts Jr, James I Freeman, James I Freeman, Mike Litchford, Reynie Rutledge, Tom W Bolin, Tony J Bolte and Warren A Stephens.
View institutional ownership trends
.

How do I buy shares of Dillard's?

Shares of DDS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:DDS) was last updated on 4/21/2024 by MarketBeat.com Staff

From Our Partners